Book Value per Share: Procaps (PROC)

Graphic logo of Procaps Group S.A. (PROC)

Profit growth for Procaps Group S.A. (PROC) is constrained by compliance costs amid moderate operating leverage. The key book value metric reflects equity dynamics, where 0.00 determines the latest valuation figure. This underscores the significance of the Softgel ecosystem for global pharmaceutical leaders. The company's high-tech cGMP plants located in the US, Brazil, and Colombia ensure supply stability.

Procaps Group (PROC): Share Book Value from 07/04/2022 to 02/16/2025

procapsgroup.com - analytical breakdowns and key metrics (PROC)

- price and consensus price forecast:
Price Chart Procaps Group SA|PROC - Average Forecast Price
- market capitalization data:
Market Capitalization Procaps Group|PROC - Real Price to Acquire Entire Company
- book capitalization data:
Net Assets per Single Share Procaps|PROC - Net Asset Value|Market Capitalization to Book Value Ratio procapsgroup.com|PROC - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Procaps Group S.A.|PROC - Long-Term Debt to Capital|Short-Term Debt to Equity Procaps|PROC - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Procaps Group
Fundamental company valuation:Procaps Group SA - PROC
Manufactured products of Procaps

Book value per share measures the portion of equity attributable to a single security, which determines the intrinsic asset value of the business. The BVPS trend depends directly on quarterly reporting, reflecting the efficiency of asset capitalization at Procaps Group S.A. (PROC) during the implementation of ESG environmental standards and the modernization of pharmaceutical production treatment systems.

Competitors of Procaps Group S.A. (PROC)

HLN (Haleon Group) - Net Assets per Single Share|KVUE - Net Asset Value per Share|VRNA (Verona Pharma plc) - Book Value per Share|MENS (jyongbio.com) - Accounting Value per Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|glpg.com - Book Value per Share|Net Assets per Single Share ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of a Share|AMPH (Amphastar) - Net Assets per Single Share|Pacira Corp (PCRX) - Accounting Value per Share|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Accounting Value per Share|Accounting Value of a Share SCPH (scpharmaceuticals.com)|TECX: Net Assets per Single Share|TNXP - Net Asset Value per Share|Accounting Value per Share SXT China SXTC|EPRX - Book Price of a Share|Book Value per Share BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Accounting Value of a Share|Book Value per Share ORMP (Oramed)|Net Asset Value per Share ENTX|MindWalk Holdings (HYFT) - Net Assets per Single Share|Accounting Value of a Share ABVC (abvcpharma.com)|Cumberland Pharmaceuticals Inc. (CPIX) - Net Assets per Single Share|Quantum BioPharma Ltd. - Share Book Value|Net Assets per Single Share FibroGen Corp (FGEN)|TELO: Accounting Value of a Share|Net Assets per Single Share RANI|Synergy CHC (SNYR) - Net Asset Value per Share|Book Value per Share RLYB|Accounting Value per Share Lexaria|Book Value per Share PULM|Book Value per Share PTHL (ftzy.com.cn)|Aptorum Group (APM) - Net Assets per Single Share|lyratherapeutics.com - Share Book Value|Net Assets per Single Share IBO (Impact BioMedical Inc)|TNF Pharmaceuticals (TNFA) - Net Assets per Share|Accounting Value per Share cbdmd.com YCBD|PainReform Corp (PRFX) - Accounting Value of a Share|Altamira Therapeutics Ltd - Book Value per Share|Book Value of One Share LIPO|OptiNose (OPTN) - Net Assets per Single Share|Accounting Value of a Share PIRS (Pieris Pharmaceuticals Inc)|PTPI: Net Assets per Single Share|QLI - Net Asset Value per Share|Acelyrin, Inc. - Accounting Value per Share|TFFP: Book Value per Share